Skip to main content

Boston Partners

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1386060 BOSTON, MA

Position in HALO

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$173,446,430
+$140,666,688 QoQ
Shares Held
2,683,683
+451.0% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 93.03624906518392.ToString("F0")% Shared 0.ToString("F0")% None 6.963750934816073.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Boston Partners holds $301,190,357 across 5 Biotechnology names. HALO ranks #1 (57.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
This page
2,683,683 $173,446,430

All Filings in HALO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $173,446,430 2,683,683
2025-12-31 $32,779,742 487,069
2025-09-30 $32,621,850 444,803
2025-06-30 $23,376,018 449,366
2025-03-31 $26,565,696 416,325
2024-12-31 $19,505,714 407,984
2024-09-30 $32,738,244 571,947
2024-06-30 $38,178,134 729,147
2024-03-31 $25,643,369 630,368
2023-12-31 $20,416,406 552,392
2023-09-30 $3,186,453 83,415